What is Pf-08046052 used for?

Pf-08046052 is indicated for Indication not found, Indication not found.

Who makes Pf-08046052?

Pf-08046052 is developed by Pfizer.

What development phase is Pf-08046052 in?

Pf-08046052 is FDA-approved (marketed).

What is the generic name of Pf-08046052?

pf-08046052 is the generic (nonproprietary) name of Pf-08046052.

Last reviewed 2026-04-20 · How we verify

Pf-08046052 (pf-08046052)

Pfizer · FDA-approved active Quality 22/100

At a glance

Generic name	pf-08046052
Sponsor	Pfizer
Drug class	Unknown
Target	Unknown
Therapeutic area	Other
Phase	FDA-approved

Approved indications

Indication not found
Indication not found

Common side effects

No common side effects on file.

Drug interactions

Warfarin
Aspirin
Clopidogrel
Pentosan polysulfate
Dabigatran
Rivaroxaban
Apixaban
Esomeprazole
Omeprazole
Lansoprazole
Pantoprazole
Rabeprazole

Key clinical trials

A Study of PF-08046052/SGN-EGFRd2 in Advanced Solid Tumors (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Pf-08046052 CI brief — competitive landscape report
Pf-08046052 updates RSS · CI watch RSS
Pfizer portfolio CI